5-Amino-1MQ — Published Research

Reviewed by: Panda Peptides Research Team| Last updated: April 29, 2026|For laboratory reference only

← Back to 5-Amino-1MQ product page

How to read this 5-Amino-1MQ research page

This page summarizes 5-Amino-1MQ literature around NNMT inhibition, NAD+-pathway context, and experimental metabolic-marker models. It is a literature map and documentation companion, not a protocol or human-use resource.

  • Compound identity: 5-Amino-1MQ is discussed here as a small-molecule NNMT inhibitor research compound; CAS 42464-85-9.
  • Research framing: citations are grouped by experimental theme and should not be interpreted as product claims or intended uses.
  • Documentation links: compare the catalog listing, COA hub, and research framework.

Panda Peptides products are for research use only. No dosing, administration, treatment, outcome, metabolic-benefit, or human-use guidance is provided.

Research Library

Published research references for 5-Amino-1MQ — research reference only, not medical guidance

5-Amino-1MQ and NNMT Inhibition Models

5-Amino-1MQ has been studied as a nicotinamide N-methyltransferase (NNMT) inhibitor in adipocyte and metabolic-model research. Published work uses the compound to examine NNMT activity, NAD+ salvage-pathway markers, and cellular energy-metabolism endpoints in experimental systems.

Source: PMC5826726

NNMT Pathway Literature Context

NNMT literature provides pathway context for interpreting 5-Amino-1MQ studies, including nicotinamide methylation, methyl-donor metabolism, and cellular NAD+-related measurements. These references are useful for research orientation and assay-design background only.

Source: PMC8337113

Reviewed by

Panda Peptides Research Team

Research content review focused on published literature references, source quality, and documentation clarity.

Editorial Review

Reviewed by Elizabeth D. and James S. — Panda Peptides Research Team.

Last reviewed: August 2026.

This content summarizes published laboratory literature for research-reference purposes only. Products referenced by Panda Peptides are sold strictly for controlled laboratory, analytical, or reference use and are not consumer products.

FOR RESEARCH USE ONLY. NOT FOR HUMAN USE.

FDA Disclaimer: The content and products mentioned on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold exclusively for research, laboratory, or analytical purposes and are intended for controlled laboratory research use. The information provided is strictly for informational purposes only.

All products are sold for research, laboratory, or analytical purposes only, and are intended for controlled laboratory research use.

Xylo Research Systems LLC, dba Panda Peptides, is a chemical supplier. Xylo Research Systems LLC, dba Panda Peptides, is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Xylo Research Systems LLC, dba Panda Peptides, is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act. The statements made within this website have not been evaluated by the US Food and Drug Administration. The products we offer are not intended to diagnose, treat, cure or prevent any disease. Laboratory in-vitro experimental use only.

Copyright © 2026 Xylo Research Systems LLC, dba Panda Peptides

8139 Sunset Ave #151, Fair Oaks, CA 95628

Privacy Policy | Terms & Conditions | Shipping Policy | Return Policy | Accessibility

Do Not Sell or Share My Personal Information